January 07, 2025 05:07 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Delhi assembly elections on Feb 5, results on Feb 8 | Allu Arjun visits boy injured during Pushpa 2 stampede in Hyderabad | Donald Trump repeats his US-Canada merger offer after Justin Trudeau's resignation | India's HMPV cases surge to 7 after two cases reported from Nagpur | H-1B visa renewal will get simpler in 2025, Indians to benefit most as home country travel won't be required | As India detects 3 HMPV cases, #lockdown trends; Centre says no need to panic | Justin Trudeau announces resignation as Canada's PM amid rising pressure by partymates | 8 jawans, driver killed as Maoists blow up security vehicle in Chhattisgarh's Bijapur | Atul Subhash suicide: Karnataka High Court refuses to quash FIR against wife Nikita Singhania | Delhi elections: Congress launches Pyari Didi scheme promising Rs. 2,500 per month to women residents
Sputnik V
Image Credit: twitter.com/sputnikvaccine

Sputnik V to be available from Tuesday in Delhi's Indraprastha Apollo Hospital

| @indiablooms | Jun 14, 2021, at 03:59 am

Delhi/IBNS: Russian-made coronavirus vaccine Sputnik V will be available in Delhi's Indraprastha Apollo Hospital from Tuesday onwards.

According to the price fixed by the Centre in an order issued on June 8 last, Sputnik V will be priced at Rs 1,145, inclusive of hospital charges and tax.

Dr Reddy's Laboratories had applied for emergency use of the vaccine in February and it was given approval by India's drug regulator in April.

The vaccine will be produced by five pharma companies in the country and 850 million doses will be manufactured annually.

The vaccine has the highest efficacy rate of 91.6 per cent after Moderna and Pfizer shots.

The government has set itself the target of inoculating all eligible individuals by the end of this year.

The dire shortage in vaccine supply, which forced many states to shut down their vaccination camps, would be eased from August as the production of both Covaxin and Covishield is likely to pick up.

Earlier this month, the Centre revamped its vaccination policy and took away the responsibility of procuring and vaccinating from the states.

While announcing the new policy, Prime Minister Narendra Modi had said that the Centre will procure 75 per cent of all the vaccines produced by companies, including 25 per cent currently assigned to the states and private hospitals will continue to buy the remaining 25 per cent and vaccinate those who are willing to pay.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.